-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

623A.O1.6 623. Mantle Cell, Follicular and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Prospective Clinical Trials in Mantle Cell Lymphoma Incorporating Novel Agents

Symposia: Mantle Cell, Follicular, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Lymphomas, non-Hodgkin lymphoma, Diseases, aggressive lymphoma, Lymphoid Malignancies
Monday, December 11, 2023: 10:30 AM-12:00 PM
Grand Hall B (Manchester Grand Hyatt San Diego)
Mats Jerkeman, MD, PhD, Skane University Hospital and Lund University and Victor Yazbeck, MD, VCU Massey Cancer Center
Jerkeman: Abbvie: Honoraria, Research Funding; AstraZeneca: Honoraria, Research Funding; BMS: Honoraria, Research Funding; Janssen: Honoraria, Research Funding; Roche: Honoraria, Research Funding; Genmab: Honoraria; Pierre Fabre: Honoraria; Kite/Gilead: Honoraria. Yazbeck: ADC Therapeutics: Consultancy, Speakers Bureau; Abbvie: Consultancy, Honoraria; Astrazeneca: Consultancy, Research Funding, Speakers Bureau; Beigene: Consultancy, Research Funding, Speakers Bureau; Tg Therapeutics: Consultancy; Seattle Genetics: Consultancy.
This session contains abstracts that focus on results of prospective clinical trial in mantle cell lymphoma incorporating novel agents
10:30 AM

Craig A. Portell, MD1, Opeyemi Jegede2*, N. Nora Bennani, MD3, Seema Naik, MD4, Christopher M. Reynolds, MD, BA5, Priyank P. Patel, MD6*, Michael J. Robertson, MD7 and Brad S. Kahl, MD8

1Division of Hematology and Oncology, Department of Medicine, University of Virginia Medical Center, Charlottesville, VA
2CIMAC-CIDC Network, Department of Data Science, Boston, MA
3Mayo Clinic, Rochester, MN
4Penn State University College of Medicine, Hershey, PA
5St. Joseph Mercy Hospital, IHA Hematology-Oncology Consultants, Ypsilanti, MI
6Carle Cancer Center, Urbana, IL
7Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN
8Washington University School of Medicine in St. Louis, Saint Louis, MO

10:45 AM

Michael L. Wang, MD1, Sarit Assouline, MD2, Manali Kamdar, MD3*, Nilanjan Ghosh, MD, PhD4, Seema Naik, MD5*, Shazia K. Nakhoda, MD6*, Julio C. Chavez, MD7*, Ting Jia, MD8*, Song Pham, MSc9*, Ling-Yuh Huw, PhD10*, Jing Jing, PhD10*, Wahib Ead, PharmD10*, Iris To, PharmD10*, Connie Lee Batlevi, MD10*, Michael C. Wei, MD, PhD10 and Elizabeth Lihua Elizabeth Budde, MD, PhD11

1University of Texas MD Anderson Cancer Center, Houston, TX
2Jewish General Hospital, McGill University, Montreal, QC, Canada
3Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Denver, CO
4Atrium Health Levine Cancer Institute, Charlotte, NC
5Penn State Cancer Institute, Hershey, PA
6Fox Chase Cancer Center, Philadelphia, PA
7Moffitt Cancer Center, Tampa, FL
8Roche (China) Holding Ltd, Shanghai, China
9Hoffmann-La Roche Ltd, Mississauga, ON, Canada
10Genentech, Inc., South San Francisco, CA
11City of Hope National Medical Center, Duarte, CA

11:00 AM

Eliza A Hawkes, MD1, Sze Ting Lee, MBBS, FRACP, FAANMS, PhD2*, Leonid Churilov, PhD3*, Tasman Armytage, MBBS4*, Georgina Hodges, FRACP, MBBS, FRCPA5*, Chan Yoon Cheah, MBBS6, Joel Wight7*, Nicole Wong Doo, MBBS, MD, FRACP, FRCPA8, Matthew Ku, MBBS, PhD9, Stephen S. Opat, MBBS, FRACP, FRCPA10, Tara Cochrane, MBBS, FRCPA, FRACP11, Greg Hapgood, M.D., Ph.D12*, Hui-Peng Lee, MD13*, Rishu Agarwal14*, Wendi Lin15*, Minu Koshy16*, Mannu Walia, PhD17*, Liudmyla Olenko18*, Paul Sung-Hao Yeh, MBBS, PhD19*, Bianca Devitt, MBBS, FRACP, PhD20* and Allison A Barraclough, BSc, FRACP, FRCPA, MBBS21

1Dept of Haematology & Medical Oncology and Olivia Newton John Cancer Research Institute, Austin Health, Melbourne, Australia
2Dept Molecular Imaging and Therapeutics, Austin Health, Heidelberg, VIC, Australia
3University of Melbourne, Parkville, AUS
4Gosford Hospital, Gosford, Australia
5Clinical Haematology, Barwon Health, Geelong, Australia
6The University of Western Australia, Perth, Australia
7Dept Haematology, Townsville Hospital, Townsville, AUS
8Department of Haematology, Concord Hospital, University of Sydney, New South Wales, Australia, Concord, NSW, AUS
9St Vincent's Hospital, Melbourne, AUS
10School of Clinical Sciences, Monash University, Melbourne, VIC, Australia
11Department of Haematology, Gold Coast University Hospital, Southport, Australia
12Princess Alexandra Hospital, Brisbane, AUS
13Flinders Hospital, Adelaide, Australia
14Pathology, Austin Health, MOUNT WAVERLEY, AUS
15Dept Pathology, Austin Health, Heidelberg, AUS
16Dept Pathology, Austin Health, Heidelberg, Australia
17Australasian Leukaemia and Lymphoma Group, Melbourne, Australia
18University of Melbourne, Parkville, Australia
19Monash Health/Monash University, Clayton, VIC, AUS
20Medical Oncology, Eastern Health Clinical School, Box Hill, Australia
21Haematology Department Fiona Stanley Hospital Murdoch, wa, Australia

11:15 AM

Huilai Zhang, MD1*, Liping Su2*, Lihong Liu3*, Ou Bai, MD/PhD4*, Zheng Song1*, Zhiqiang Zhao2*, Cuiying He3*, Qiang Guo5*, Xianhuo Wang, MD1*, Wei Li1*, Lihua Qiu1*, Lanfang Li1*, Shiyong Zhou1*, Yue Fei1*, Xiaohui Wang1* and Bin Meng1*

1Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
2Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China
3The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
4The First Hospital of Jilin University, Changchun, Jilin, China
5The First Bethune Hospital of Jilin University, Changchun, China

11:30 AM

Carlo Visco1*, Valentina Tabanelli2*, Maria Vittoria Sacchi3*, Andrea Evangelista4*, Isacco Ferrarini5*, Maria Chiara Tisi6*, Anna Merli7*, Stefano Fiori8*, Vittorio Ruggero Zilioli9*, Alessandro Re, MD10*, Claudia Castellino, MD11*, Francesco Piazza, MD12*, Paolo Corradini, MD13, Stefan Hohaus14*, Gerardo Musuraca, MD, PhD15*, Francesca Gaia Rossi16*, Benedetta Puccini, MD17*, Federica Cavallo18*, Filippo Ballerini, MD19*, Roberta Sciarra20*, Alice Di Rocco21*, Annalisa Arcari, MD22*, Carola Boccomini, MD23*, Francesco Merli, MD24*, Guido Gini, MD25, Monica Tani26*, Riccardo Bruna27*, Vincenzo Pavone, MD28*, Andrés José María Ferreri, MD29, Armando Santoro, MD30*, Caterina Patti, MD31*, Giacomo Loseto, MD32*, Marco Ladetto33, Michele Merli34*, Michele Spina, MD35*, Pier Luigi Zinzani, MD, PhD36, Piero Maria Stefani37*, Sara Usai, MD38*, Stefano Pileri2 and Monica Balzarotti, MD39*

1Department of Engineering for Innovation Medicine/Section of Hematology, University of Verona, Verona, Italy
2Haematopathology Division, IEO European Institute of Oncology IRCCS, Milan, Italy
3Fondazione Italiana Linfomi, Onlus, Alessandria, Italy
4Unit of Cancer Epidemiology, A.O.U Città della Salute e della Scienza di Torino, Torino, Italy
5Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy
6ULSS 8 Berica - Ospedale S. Bortolo - Ematologia, Vicenza, ITA
7Ospedale degli Infermi di Rimini - U.O. di Ematologia, Rimini, ITA
8Istituto Europeo di Oncologia (IEO) - Haematopathology Unit, Milano, Italy
9Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
10UC Hematology, ASST Spedali Civili di Brescia, Brescia BS, Italy
11SC Ematolgoa, Ospedale Santa Croce e Carle, Cuneo, Italy
12University of Padua, Padova, Italy
13University of Milan and Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
14Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
15IRCCS Istituto Romagnolo per lo studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy
16Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, ITA
17Unitа Ematologia, Azienda Ospedaliero Universitaria Careggi, Firenze, Italy
18Division of Hematology and Stem Cell Transplant Unit, AOU Città della Salute e della Scienza, Torino, Italy
19IRCCS Ospedale Policlinico San Martino, Genoa, Italy
20Fondazione IRCCS Policlinico San Matteo, Pavia, ITA
21Policlinico Umberto I, Roma, ITA
22UO Ematologia, Ospedale Guglielmo da Saliceto, Piacenza, Italy
23SC Ematologia, AOU Città della Salute e della Scienza, Torino, Italy
24SC Ematologia, IRCCS - Arcispedale Santa Maria Nuova, REGGIO EMILIA, ITA
25Hematology Unit, AUO Ospedali Riuniti, Università Politecnica delle Marche, Ancona, ITA
26Ematologia, Ospedale Santa Maria delle Croci, Ravenna, Italy
27Universit� Del Piemonte Orientale Amedeo Avogadro, Novara, ITA
28Hematology Unit, Azienda C. Panico, Tricase, Italy
29Unit of Lymphoid Malignancies, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
30IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Rozzano, Milan, Italy
31Division of Hematology 1, Azienda Ospedali Riunita Villa Sofia-Cervello, Palermo, Italy
32IRCCS Istituto Tumori “Giovanni Paolo II”, Hematology Unit, Bari, Italy
33Department of Translational Medicine, Università del Piemonte Orientale SCDU Ematologia SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
34Ospedale Di Circolo E Fondazione Macchi Varese, Varese, ITA
35Division of Medical Oncology, IRCCS Centro Di Riferimento Oncologico, Aviano, Italy
36Hematology, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
37Ospedale Ca Foncello - S.C di Ematologia, Treviso, ITA
38Ospedale Oncologico Armando Businco, Cagliari, ITA
39Humanitas Research Hospital IRCCS, Rozzano Milano, Italy

11:45 AM

Anita Kumar, MD1, Jacob Soumerai, MD2, Jeremy S. Abramson, MD3, Jeffrey A. Barnes, MD, PhD4, Philip Caron, MD5, Maria Chabowska, BSc6*, Mary Devlin7*, Ahmet Dogan, MD, PhD8, Lorenzo Falchi, MD9, Rayna N. Garcia7*, Clare Grieve, MPH6*, Emma Haskell7*, Julie E. Haydu, MD PhD3*, Patrick Connor Johnson, MD10, Ashlee Joseph11*, Hailey E. Kelly7*, Alyssa Labarre6*, Emerald D Littlejohn, MPH12*, Jennifer Kimberly Lue6*, Joanna Mi6*, Rosalba Martignetti3*, Grace McCambridge7*, Alison Moskowitz, MD6, Colette Owens, MD5, Sean F. Plummer7*, Madeline G. Puccio7*, Gilles Salles, MD, PhD9, Venkatraman Seshan, PhD6*, Natalie Slupe6* and Andrew D. Zelenetz, MD, PhD5

1Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
2Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA
3Massachusetts General Hospital Cancer Center, Boston, MA
4Massachusetts General Hosp. Cancer Ctr., Boston, MA
5Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Memorial Sloan Kettering Cancer Center, New York, NY
7Massachusetts General Hospital, Boston, MA
8Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY
9Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
10Cancer Center, Massachusetts General Hospital, Boston, MA
11Memorial Sloan Kettering Cancer Center, New York
12Dana-Farber Cancer Institute, Boston, MA

*signifies non-member of ASH